Beutler test

The Beutler test, also known as the fluorescent spot test,[1] is a screening test used to identify enzyme defects.[2][3][4]

It can be used in screening for:

References

  1. ^ Markić J, Krzelj V, Markotić A, et al. (August 2006). "High incidence of glucose-6-phosphate dehydrogenase deficiency in Croatian island isolate: example from Vis island, Croatia". Croat. Med. J. 47 (4): 556–70. PMC 2080441. PMID 16909453. http://www.cmj.hr/2006/47/4/16909453.htm. 
  2. ^ Beutler E, Baluda MC. A simple spot screening test for galactosemia. J Lab Clin Med 1966;68:137-141.
  3. ^ Beutler E, Baluda M, Donnell GE. A new method for the detection of galactosemia and its carrier state. J Lab Clin Med 1964;64:695-705.
  4. ^ Beutler E, Mitchell M. New rapid for the estimation of red cell galactose-1-phosphate uridyl transferase activity. J Lab Clin Med 1968;72:527-532.
  5. ^ Fujimoto A, Okano Y, Miyagi T, Isshiki G, Oura T (1999). "Mass screening of galactosemia: improved Beutler Test using automated quantitative fluorescence assay". Southeast Asian J. Trop. Med. Public Health 30 Suppl 2: 69. PMID 11400789. 
  6. ^ Fujimoto A, Okano Y, Miyagi T, Isshiki G, Oura T (June 2000). "Quantitative Beutler test for newborn mass screening of galactosemia using a fluorometric microplate reader". Clin. Chem. 46 (6 Pt 1): 806–10. PMID 10839768. http://www.clinchem.org/cgi/pmidlookup?view=long&pmid=10839768. 
  7. ^ Kirimlidis S, Politis E, Drossos C, Scaloumbakas N, Papaioannou M (November 1965). "Glucose-6-phosphate-dehydrogenase deficiency in Greece. Study by using a modification of Beutler and Fair- banks spot test". Helv Paediatr Acta 20 (5): 490–6. PMID 5895109. 
  8. ^ DERITIS L (April 1963). "[THE FAIRBANKS AND BEUTLER TEST FOR THE ROUTINE DETECTION OF ERYTHROCYTE DEFICIENCY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE.]" (in Italian). Riv Clin Pediatr 71: 242–4. PMID 14074804. 

Further reading

Endocrine disease
Nutrition disorders
Metabolic disorders
            hypocalcaemia
Other
Beutler test

M: END

anat/phys/devp/horm

noco(d)/cong/tumr, sysi/epon

proc, drug (A10/H1/H2/H3/H5)

M: NUT

cof, enz, met

noco, nuvi, sysi/epon, met

drug(A8/11/12)

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m(A16/C10),i(k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)